Johannes Spleiss
Technik-/Wissenschafts-/F&E-Leiter bei Tillotts Pharma AG
Ursprung des Netzwerks ersten Grades von Johannes Spleiss
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Tillotts Pharma AG
Tillotts Pharma AG Pharmaceuticals: MajorHealth Technology Tillotts Pharma AG manufactures pharmaceuticals for treatment of gastrointestinal diseases. The firm specializes in the therapy of the lower gastrointestinal tract. It offers Asacol, Entocort, Colpermin, Tillhepo and VistaPrep. The company was founded in 1986 and is headquartered in Ziefen, Switzerland.
7
| Subsidiary | Pharmaceuticals: Major | 7 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Johannes Spleiss
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
ZERIA PHARMACEUTICAL CO., LTD. | Pharmaceuticals: Major | Chief Executive Officer Comptroller/Controller/Auditor Director/Board Member President | |
Boston University | College/University | Masters Business Admin | |
Bayer Pharma AG
Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistik
International
Japan | 2 |
Israel | 2 |
Deutschland | 2 |
Sektoral
Health Technology | 3 |
Consumer Services | 2 |
Operativ
Director/Board Member | 7 |
Corporate Officer/Principal | 3 |
Chief Executive Officer | 2 |
Chairman | 2 |
President | 2 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Johannes Spleiss
- Unternehmensverbindungen